Commentary on the impact of the COVID-19 passports in Lithuania - 28/02/23

Doi : 10.1016/j.jinf.2022.12.013

Rimas Jankunas ^a,^b,^⁎ , Leonidas Sakalauskas ^b,^c, Kristina Zamaryte-Sakaviciene ^b,^d, Donatas Stakisaitis ^a,^e, Migle Helmersen ^f
^a Medical Academy, Lithuanian University of Health Sciences, Mickeviciaus str. 9, Kaunas 44307, Lithuania
^b Health Law Institute, Ulonų g. 5-303, Vilnius 08240, Lithuania
^c Klaipėda University, H. Manto 84, Klaipėda 92294, Lithuania
^d Faculty of Law, Mykolas Romeris University, Ateities g. 20, Vilnius 08303, Lithuania
^e National Cancer Institute, Vilnius 08660, Lithuania
^f Department of Public Health, University of Agder, 4625, Norway

^⁎Corresponding author at: Medical Academy, Lithuanian University of Health Sciences, Mickeviciaus str. 9, Kaunas 44307, Lithuania.Medical AcademyLithuanian University of Health SciencesMickeviciaus str. 9Kaunas44307Lithuania

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Highlights

•	With the COVID-19 passports, Lithuania had the highest excess mortality in the Baltic region.
•	There is no scientific evidence that COVID-19 passports prevented deaths in Lithuania.
•	The mathematical assessment demonstrating the benefits of the COVID-19 passports is inappropriate.
•	There is no scientific evidence that COVID-19 passports could help control future epidemics.

Le texte complet de cet article est disponible en PDF.